Prozkoumejte nejčtenější články a videa na Campus Sanofi
T1D is an autoimmune disease whereby autoreactive T-cells drive progressive beta-cell damage and destruction, ultimately leading to insulin deficiency, dysglycemia, and hyperglycemia.
Monitoring people with early-stage autoimmune T1D may reduce the risk of serious complications, such as DKA.
Why and Who: an overview of the key considerations and decisions that inform screening people for islet autoantibodies.
The burden associated with a diagnosis of autoimmune T1D can be wide-ranging. This video describes the impact of diagnosis on an individual and their family.
Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S-1 for clinical stage III gastric or esophagogastric junction adenocarcinoma Kurokawa Y, et al. Ann Gastroenterol Surg. 2022 Oct 18;7(2):247-254.